Immunophenotyping in multiple myeloma and related plasma cell disorders

被引:89
作者
Kumar, Shaji [1 ]
Kimlinger, Teresa
Morice, William
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
关键词
monoclonal gammopathy; myeloma; plasma cell; immunophenotyping; MULTIPARAMETER FLOW-CYTOMETRY; MINIMAL RESIDUAL DISEASE; LOW CD27 EXPRESSION; HIGH-DOSE THERAPY; BONE-MARROW; PERIPHERAL-BLOOD; MONOCLONAL GAMMOPATHY; LABELING INDEXES; UNDETERMINED SIGNIFICANCE; C-KIT;
D O I
10.1016/j.beha.2010.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma cell disorders form a spectrum ranging from the asymptomatic presence of small monoclonal populations of plasma cells to conditions like plasma cell leukemia and multiple myeloma, in which the bone marrow can be replaced by the accumulation of neoplastic plasma cells. Immunophenotyping has become an invaluable tool in the management of hematological malignancies and is increasingly finding a role in the diagnosis and monitoring of plasma cell disorders. Multiparameter flow cytometry has evolved considerably during the past decade with an increasing ability to screen large numbers of events and to detect multiple antigens at the same time. This, along with a better understanding of the phenotypic heterogeneity of the clonal plasma cells in different disorders, has made immunophenotyping an indispensible tool in the diagnosis, prognostic classification and management of plasma cell disorders. This book chapter addresses the approaches taken to evaluate monoclonal plasma cell disorders, and the different markers and techniques that are important for the study of these diseases. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:433 / 451
页数:19
相关论文
共 50 条
  • [21] Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis
    Visram, Alissa
    Vachon, Celine
    Baughn, Linda B.
    Larson, Dirk
    Smadbeck, James
    Dispenzieri, Angela
    Kapoor, Prashant
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Dingli, David
    Kourelis, Taxiarchis
    Gonsalves, Wilson
    Warsame, Rahma
    Muchtar, Eli
    Leung, Nelson
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji
    LEUKEMIA, 2022, 36 (04) : 1058 - 1065
  • [22] Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias
    Willrich, Maria A. V.
    Katzmann, Jerry A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (06) : 907 - 919
  • [23] Multiple myeloma immunophenotyping: method validation
    Vergnolle, Ines
    Rieu, Jean-Baptiste
    Avet-Loiseau, Herve
    Corre, Jill
    Vergez, Francois
    ANNALES DE BIOLOGIE CLINIQUE, 2019, 77 (02) : 197 - 217
  • [24] Multiple myeloma immunophenotyping: method validation
    Vergnolle, Ines
    Rieu, Jean-Baptiste
    Avet-Loiseau, Herve
    Corre, Jill
    Vergez, Francois
    HEMATOLOGIE, 2019, 25 (05): : 248 - 272
  • [25] The potential role of mass spectrometry for the identification and monitoring of patients with plasma cell disorders: Where are we now and which questions remain unanswered?
    Giles, Hannah, V
    Wechalekar, Ashutosh
    Pratt, Guy
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (04) : 641 - 653
  • [26] Towards Stratified Medicine in Plasma Cell Myeloma
    Egan, Philip
    Drain, Stephen
    Conway, Caroline
    Bjourson, Anthony J.
    Alexander, H. Denis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (10)
  • [27] Host-related immunodeficiency in the development of multiple myeloma
    Dosani, Talib
    Mailankody, Sham
    Korde, Neha
    Manasanch, Elisabet
    Bhutani, Manisha
    Tageja, Nishant
    Roschewski, Mark
    Kwok, Mary
    Kazandjian, Dickran
    Costello, Rene
    Burton, Debra
    Zhang, Yong
    Liewehr, David
    Steinberg, Seth M.
    Maric, Irina
    Landgren, Ola
    LEUKEMIA & LYMPHOMA, 2018, 59 (05) : 1127 - 1132
  • [28] Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method
    Manasanch, Elisabet E.
    Salem, Dalia A.
    Yuan, Constance M.
    Tageja, Nishant
    Bhutani, Manisha
    Kwok, Mary
    Kazandjian, Dickran
    Carter, George
    Steinberg, Seth M.
    Zuchlinski, Diamond
    Mulquin, Marcia
    Calvo, Katherine
    Maric, Irina
    Roschewski, Mark
    Korde, Neha
    Braylan, Raul
    Landgren, Ola
    Stetler-Stevenson, Maryalice
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1416 - 1424
  • [29] Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias
    Ozsan, Guner Hayri
    Dispenzieri, Angela
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (01) : 65 - 73
  • [30] Multiparameter immunophenotyping by flow cytometry as a diagnostic tool in multiple myeloma and monoclonal gammopathy of undetermined significance
    Carulli, G.
    Ottaviano, V.
    Cannizzo, E.
    Giuntini, S.
    Manetti, C.
    Ciancia, E. M.
    Azzara, A.
    CLINICA TERAPEUTICA, 2012, 163 (05): : 387 - 392